Psmb5 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | PSMB5 |
| Full Name | Proteasome Subunit Beta 5 |
| Chromosomal Location | 14q11.2 |
| NCBI Gene ID | 5693 |
| OMIM | 176850 |
| Ensembl ID | ENSG00000100812 |
| UniProt | P28074 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease |
PSMB5 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of PSMB5 is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The PSMB5 gene encodes the β5 subunit of the 20S proteasome, which provides the chymotrypsin-like (post-glutamyl peptide hydrolyzing) proteolytic activity. PSMB5 is the major proteolytic component and cleaves after hydrophobic residues.
PSMB5 is the target of the drug bortezomib, a proteasome inhibitor used in cancer therapy. The chymotrypsin-like activity is considered the rate-limiting step of proteasome-mediated protein degradation.
PSMB5 in neurodegeneration:
PSMB5 is ubiquitously expressed:
The study of Psmb5 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.